CA2773544C - Core stabilized microcapsules, method of their preparation and uses thereof - Google Patents

Core stabilized microcapsules, method of their preparation and uses thereof Download PDF

Info

Publication number
CA2773544C
CA2773544C CA2773544A CA2773544A CA2773544C CA 2773544 C CA2773544 C CA 2773544C CA 2773544 A CA2773544 A CA 2773544A CA 2773544 A CA2773544 A CA 2773544A CA 2773544 C CA2773544 C CA 2773544C
Authority
CA
Canada
Prior art keywords
process according
microcapsules
metal oxide
agent
phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2773544A
Other languages
English (en)
French (fr)
Other versions
CA2773544A1 (en
Inventor
Ofer Toledano
Haim Bar-Simantov
Hanan Sertchook
Sharon Fireman-Shoresh
Dorit Marco-Dagan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sol Gel Technologies Ltd
Original Assignee
Sol Gel Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sol Gel Technologies Ltd filed Critical Sol Gel Technologies Ltd
Publication of CA2773544A1 publication Critical patent/CA2773544A1/en
Application granted granted Critical
Publication of CA2773544C publication Critical patent/CA2773544C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/38—Percompounds, e.g. peracids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/14—Polymerisation; cross-linking
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CA2773544A 2009-12-31 2010-12-30 Core stabilized microcapsules, method of their preparation and uses thereof Active CA2773544C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29159409P 2009-12-31 2009-12-31
US61/291,594 2009-12-31
PCT/IL2010/001092 WO2011080741A2 (en) 2009-12-31 2010-12-30 Core stabilized microcapsules, method of their preparation and uses thereof

Publications (2)

Publication Number Publication Date
CA2773544A1 CA2773544A1 (en) 2011-07-07
CA2773544C true CA2773544C (en) 2019-02-12

Family

ID=44226918

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2773544A Active CA2773544C (en) 2009-12-31 2010-12-30 Core stabilized microcapsules, method of their preparation and uses thereof

Country Status (13)

Country Link
US (2) US10512796B2 (https=)
EP (1) EP2467132B1 (https=)
JP (1) JP5934107B2 (https=)
KR (1) KR20130008002A (https=)
CN (1) CN102596186B (https=)
AU (1) AU2010337830B2 (https=)
BR (1) BR112012012023A2 (https=)
CA (1) CA2773544C (https=)
EA (1) EA201200347A1 (https=)
ES (1) ES2611499T3 (https=)
MX (1) MX344128B (https=)
WO (1) WO2011080741A2 (https=)
ZA (1) ZA201203582B (https=)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008211554B2 (en) 2007-02-01 2013-12-19 Sol-Gel Technologies Ltd. Method for preparing particles comprising metal oxide coating and particles with metal oxide coating
CN102112219A (zh) 2008-07-31 2011-06-29 溶胶凝胶技术公司 包含有效成分和金属氧化物壳的微胶囊,其制备方法及其用途
US11071878B2 (en) 2009-12-31 2021-07-27 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
US10653899B2 (en) 2009-12-31 2020-05-19 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
BR112012012023A2 (pt) 2009-12-31 2016-05-17 Sol Gel Technologies Ltd processo para preparar microcápsulas, microcápsulas, composição, método para tratar uma condição superficial em um indivíduo, e, uso das microcápsulas
EP2726067B1 (en) 2011-06-29 2020-02-19 Sol-Gel Technologies Ltd. Stabilized topical formulations containing core-shell microcapsules
US8633178B2 (en) 2011-11-23 2014-01-21 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150132492A1 (en) * 2012-04-18 2015-05-14 Rohm And Haas Company Wax-biocide wood treatment
US10806697B2 (en) * 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CN102726383B (zh) * 2012-07-05 2015-03-18 常州美胜生物材料有限公司 一种缓释型害虫引诱剂微胶囊及其制备方法
FI126168B (en) 2012-09-18 2016-07-29 Novaldmedical Ltd Oy A method for coating pharmaceutical substrates
CA2889199C (en) * 2012-11-27 2020-05-19 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
CN104624125B (zh) * 2013-11-11 2018-03-02 中国人民银行印制科学技术研究所 一种光致变色双壳微胶囊及其制备方法和应用
CN103908912A (zh) * 2014-03-13 2014-07-09 安徽明讯新材料科技有限公司 一种相变恒温配胶容器
US9480960B2 (en) * 2014-12-01 2016-11-01 National Chung Shan Institute Of Science And Technology Process for preparing phase change microcapsule having thermally conductive shell
EP3294420B1 (en) * 2015-05-13 2025-08-06 Unilever Global IP Limited Benefit delivery particle and composition comprising the particle
WO2017029665A1 (en) 2015-08-20 2017-02-23 Sol-Gel Technologies Ltd. Compositions for topical application comprising benzoyl peroxide and adapalene
KR101779846B1 (ko) 2015-08-31 2017-10-10 주식회사 티케이케미칼 나노다공성을 갖는 서방성 미분말과 그 제조방법
CN105754554B (zh) * 2016-02-02 2019-02-19 中南林业科技大学 一种含纳米TiO2的纤维素基低温相变储能微胶囊及其制备方法
WO2017147318A1 (en) 2016-02-23 2017-08-31 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens
EP3423030B1 (en) * 2016-03-04 2024-04-24 Arkema, Inc. Encapsulation of peroxides for skin applications
CN105797659B (zh) * 2016-04-08 2018-12-14 东南大学 一种二氧化硅壳聚糖双壳储热微胶囊的制备方法
EP3651755A4 (en) 2017-07-12 2021-03-24 Sol-Gel Technologies Ltd. METHODS AND COMPOSITIONS FOR TREATMENT OF ACNE
EP3651756B1 (en) * 2017-07-12 2025-09-03 Sol-Gel Technologies Ltd. Compositions comprising encapsulated tretinoin
CN107213806B (zh) * 2017-07-13 2018-03-06 广州达济医学科技有限公司 一种用于滤除白细胞的滤膜及其制备方法
US11643584B2 (en) * 2017-11-16 2023-05-09 Georgia Tech Research Corporation Incorporation of microencapsulated phase change materials into wet-spin dry jet polymeric fibers
CN111712235A (zh) 2018-01-16 2020-09-25 应用材料公司 金属氧化物包封的药物组合物及其制备方法
CN109338135B (zh) * 2018-10-11 2020-07-14 西北工业大学 一种核壳结构Al@Ti-Al2O3相变蓄热复合材料及制备方法
RU2701030C1 (ru) * 2018-12-29 2019-09-24 Федеральное государственное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) Способ получения полых кремнеземных нанокапсул
US20200261395A1 (en) 2019-02-19 2020-08-20 Sol-Gel Technologies Ltd. Method for treatment of rosacea
EP3956054A1 (en) 2019-04-17 2022-02-23 The Procter & Gamble Company Methods of making capsules
CA3135389C (en) 2019-04-17 2023-11-07 The Procter & Gamble Company Capsules
CN113631695A (zh) 2019-04-17 2021-11-09 宝洁公司 胶囊
CN114080212B (zh) * 2019-07-09 2024-12-27 株式会社Lg生活健康 化妆品用胶囊
EP4021421A4 (en) 2019-08-27 2023-05-10 Applied Materials, Inc. VAPOR PHASE COATINGS FOR PHARMACEUTICAL SOLUTION CONTROL
WO2021132729A1 (ja) * 2019-12-27 2021-07-01 花王株式会社 マイクロカプセルの製造方法
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
US12491163B2 (en) 2020-05-22 2025-12-09 Mayne Pharma Llc Stabilized microcapsules, method of their preparation and uses thereof
TWI870622B (zh) 2020-10-02 2025-01-21 美商應用材料股份有限公司 製備氧化矽塗佈藥品的低溫處理
US12458942B2 (en) 2020-10-16 2025-11-04 The Procter & Gamble Company Capsules
EP4229162B1 (en) 2020-10-16 2026-05-06 The Procter & Gamble Company Laundry care additive particles
CN116368210B (zh) 2020-10-16 2025-07-18 宝洁公司 含有核/壳胶囊的水溶性单位剂量制品
EP4229166B1 (en) 2020-10-16 2025-10-08 The Procter & Gamble Company Liquid fabric care compositions comprising capsules
MX2023004226A (es) 2020-10-16 2023-04-21 Procter & Gamble Composiciones antitranspirantes y desodorantes que comprenden capsulas.
CN112143476B (zh) * 2020-10-21 2022-03-04 南京工业大学 一种采用微流场反应技术制备纳米包覆驱油剂的方法及装置
US12594534B2 (en) 2020-12-28 2026-04-07 Kao Corporation Microcapsule
JP7654017B2 (ja) * 2020-12-28 2025-03-31 花王株式会社 シリカマイクロカプセルの製造方法
CN116806141A (zh) * 2020-12-29 2023-09-26 株式会社Lg生活健康 利用矿物质材料的有效成分稳定化方法
WO2023056304A1 (en) 2021-09-30 2023-04-06 Applied Materials, Inc. Low temperature silicon oxide coating for pharmaceutical applications
CN116919939B (zh) * 2022-04-02 2026-02-03 南京毓浠医药技术有限公司 一种维a酸和过氧化苯甲酰组合物及其制备方法和用途
US12275885B2 (en) * 2022-07-13 2025-04-15 King Fahd University Of Petroleum And Minerals Doped phase change material and method of preparation thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906108A (en) 1973-10-12 1975-09-16 Johnson & Johnson Stabilized tretinoin cream emulsion
GB9021061D0 (en) 1990-09-27 1990-11-07 Unilever Plc Encapsulating method and products containing encapsulated material
JP3050601B2 (ja) 1993-02-26 2000-06-12 エスティー ローダー インコーポレーテッド 二酸化チタン分散液、化粧品組成物およびそれを使用する方法
US5401517A (en) 1993-11-15 1995-03-28 Elizabeth Arden Company, Division Of Conopco, Inc. Cosmetic method for treatment of skin
US5720949A (en) 1996-05-06 1998-02-24 Bristol-Myers Squibb Company Foamable cosmetic mask product
US5891476A (en) 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
ES2216360T3 (es) 1998-02-06 2004-10-16 Seiwa Kasei Co., Ltd. Microcapsula con pared particular y su procedimiento de fabricacion.
US6099894A (en) 1998-07-27 2000-08-08 Frisby Technologies, Inc. Gel-coated microcapsules
WO2000009652A2 (en) 1998-08-13 2000-02-24 Sol-Gel Technologies Ltd. Method for the preparation of oxide microcapsules loaded with functional molecules and the products obtained thereof
US6468509B2 (en) 1998-12-18 2002-10-22 Sol-Gel Technologies Ltd. Sunscreen composition containing sol-gel microcapsules
US6238650B1 (en) 1999-05-26 2001-05-29 Sol-Gel Technologies Ltd. Sunscreen composition containing sol-gel microcapsules
EP1181000B1 (en) 1999-05-25 2007-02-07 Sol-Gel Technologies Ltd. A method for obtaining photostable sunscreen compositions
EP1335693A2 (en) 2000-04-21 2003-08-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
US7758888B2 (en) 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
WO2004081222A2 (en) 2003-03-14 2004-09-23 Sol-Gel Technologies Ltd. Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same
EA008771B1 (ru) 2003-07-31 2007-08-31 Сол-Джел Текнолоджиз Лтд. Микрокапсулы, заполненные активными ингредиентами, и способ их приготовления
WO2005097056A1 (de) 2004-04-05 2005-10-20 Cognis Ip Management Gmbh Wachmischung auf basis von partialglyceriden und pentaerythritestern
DE102004017221A1 (de) 2004-04-05 2005-10-20 Cognis Ip Man Gmbh O/W-Gel-Zusammensetzungen mit Estern des Pentaerythrits oder dessen Oligomeren
EP2431089A1 (en) 2005-08-02 2012-03-21 Sol-Gel Technologies Ltd. Metal oxide coating of water insoluble ingredients
WO2007092312A2 (en) 2006-02-03 2007-08-16 Stiefel Laboratories, Inc. Topical skin treating compositions
EP2104558A2 (en) 2006-12-12 2009-09-30 Sol-Gel Technologies Ltd. Formation of nanometric core-shell particles having a metal oxide shell
JP2010517996A (ja) 2007-02-01 2010-05-27 ソル − ゲル テクノロジーズ リミテッド 過酸化物及びレチノイドを含む局所適用用組成物
KR100837558B1 (ko) 2007-04-30 2008-06-12 (주)아모레퍼시픽 이중으로 안정된 세라마이드 나노 캡슐 포함 에멀젼조성물, 그의 제조방법 및 이를 이용한 피부 화장료 조성물
US8357318B2 (en) 2007-05-08 2013-01-22 Givaudan S.A. Wax encapsulation
CN102112219A (zh) 2008-07-31 2011-06-29 溶胶凝胶技术公司 包含有效成分和金属氧化物壳的微胶囊,其制备方法及其用途
BR112012012023A2 (pt) 2009-12-31 2016-05-17 Sol Gel Technologies Ltd processo para preparar microcápsulas, microcápsulas, composição, método para tratar uma condição superficial em um indivíduo, e, uso das microcápsulas

Also Published As

Publication number Publication date
JP5934107B2 (ja) 2016-06-15
US20120202695A1 (en) 2012-08-09
EA201200347A1 (ru) 2012-07-30
MX2012006636A (es) 2012-07-10
WO2011080741A3 (en) 2011-10-13
MX344128B (es) 2016-12-06
AU2010337830B2 (en) 2013-10-03
EP2467132B1 (en) 2016-10-19
KR20130008002A (ko) 2013-01-21
EP2467132A2 (en) 2012-06-27
ES2611499T3 (es) 2017-05-09
ZA201203582B (en) 2013-01-30
CN102596186A (zh) 2012-07-18
CA2773544A1 (en) 2011-07-07
CN102596186B (zh) 2017-08-11
JP2013516404A (ja) 2013-05-13
BR112012012023A2 (pt) 2016-05-17
WO2011080741A2 (en) 2011-07-07
US20180117369A1 (en) 2018-05-03
AU2010337830A1 (en) 2012-03-22
US10512796B2 (en) 2019-12-24

Similar Documents

Publication Publication Date Title
CA2773544C (en) Core stabilized microcapsules, method of their preparation and uses thereof
US12070629B2 (en) Core stabilized microcapsules, method of their preparation and uses thereof
US10653899B2 (en) Core stabilized microcapsules, method of their preparation and uses thereof
JP6033859B2 (ja) コア−シェルマイクロカプセル含有安定化局所製剤
Lasoń et al. Influence of process parameters on properties of Nanostructured Lipid Carriers (NLC) formulation.
JP2016539161A (ja) 好ましくは親油性活性物質を含む脂質マイクロカプセル、並びにそれを含有する組成物、それらの製造のための方法、並びに皮膚科学及び化粧品におけるそれらの使用
JP6788066B2 (ja) 過酸化ベンゾイルおよびアダパレンを含む局所投与用組成物
ES3040940T3 (en) Compositions comprising encapsulated tretinoin
HK1169943B (en) Core stabilized microcapsules, method of their preparation and uses thereof
HK1169943A (en) Core stabilized microcapsules, method of their preparation and uses thereof
Sütő Development and investigation of nanostructured lipid carriers for transdermal drug delivery

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20151229

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251020

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-H100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE AND LATE FEE NOT PAID BY DEADLINE OF NOTICE

Effective date: 20260202

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260203

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260210